EIN 85-1681659

Break Through Cancer

IRS 501(c) type
501(c)(3)
Num. employees
14
Year formed
2020
Most recent tax filings
2022-12-01
NTEE code, primary
Description
Break Through Cancer supports translational research in the most challenging cancers by providing funding to teams of researchers from the five top cancer research centers, including Dana-Farber Cancer Institute and Massachusetts Institute of Technology's Koch Institute for Integrative Cancer Research. Our partner organizations are renowned for their brilliance and creativity in cancer research.
Also known as...
Commonwealth Cancer Consortium
Total revenues
$27,161,244
2022
Total expenses
$24,291,674
2022
Total assets
$102,328,231
2022
Num. employees
14
2022

Program areas at Break Through Cancer

Provides funding to teams of researchers from the five top Cancer research centers: dana-farber Cancer institute, the sidney kimmel comprehensive Cancer center at john hopkins, Massachusetts institute of technology's koch institute for integrative Cancer research, the university of Texas md anderson Cancer center, and memorial sloan kettering Cancer center in order to help intercept Cancer early, develop more effective treatments, and accelerate cures for some of the deadliest cancers.

Who funds Break Through Cancer

Grants from foundations and other nonprofits
GrantmakerDescriptionAmount
Commonwealth Foundation for Cancer ResearchSupport for Multi-Institutional Research in Cancer Indications$25,596,074
The Community FoundationHealth and Wellness$30,000
Fidelity Investments Charitable Gift FundFor Grant Recipient's Exempt Purposes$20,000
...and 1 more grant received

Personnel at Break Through Cancer

NameTitleCompensation
Lisa SchwarzChief Operating Officer and Chief Product Officer and Secretary / Chief Philanthropic Officer and Secratary / Secretary$255,235
William HulmeChief Financial Officer and Treasurer$201,275
Kari McHughChief Communications Officer$187,913
Micheal NobleChief Data Officer$145,826
Jesse BoehmChief Science Officer$240,482
...and 1 more key personnel

Financials for Break Through Cancer

RevenuesFYE 12/2022
Total grants, contributions, etc.$27,158,045
Program services$0
Investment income and dividends$3,199
Tax-exempt bond proceeds$0
Royalty revenue$0
Net rental income$0
Net gain from sale of non-inventory assets$0
Net income from fundraising events$0
Net income from gaming activities$0
Net income from sales of inventory$0
Miscellaneous revenues$0
Total revenues$27,161,244

Form 990s for Break Through Cancer

Fiscal year endingDate received by IRSFormPDF link
2022-122023-11-14990View PDF
2021-122022-10-31990View PDF
2020-122021-10-08990View PDF
Data update history
January 5, 2024
Posted financials
Added Form 990 for fiscal year 2022
January 4, 2024
Updated personnel
Identified 2 new personnel
December 31, 2023
Received grants
Identified 1 new grant, including a grant for $25,596,074 from Commonwealth Foundation for Cancer Research
December 25, 2023
Used new vendors
Identified 1 new vendor, including
December 25, 2023
Received grants
Identified 5 new grant, including a grant for $5,000,000 from Lustgarten Foundation
Nonprofit Types
Grantmaking organizationsDisease research fundraisersMedical research organizationsCharities
Issues
HealthDiseases and disordersCancer
Characteristics
Conducts researchNational levelTax deductible donationsAccepts online donations
General information
Address
101 Rogers St
Cambridge, MA 02142
Metro area
Boston-Cambridge-Newton, MA-NH
County
Middlesex County, MA
Website URL
breakthroughcancer.org/ 
Phone
(800) 757-9881
IRS details
EIN
85-1681659
Fiscal year end
December
Taxreturn type
Form 990
Year formed
2020
Eligible to receive tax-deductible contributions (Pub 78)
Yes
Categorization
NTEE code, primary
H30: Cancer Research
NAICS code, primary
813212: Health and Disease Research Fundraising Organizations
Parent/child status
Independent
Free account sign-up

Want updates when Break Through Cancer has new information, or want to find more organizations like Break Through Cancer?

Create free Cause IQ account